发明授权
US08105798B2 Cytoplasmic activity of retinoid X receptor and its regulation by ligands and dimerization
失效
类视黄醇X受体的细胞质活性及其通过配体和二聚化的调节
- 专利标题： Cytoplasmic activity of retinoid X receptor and its regulation by ligands and dimerization
- 专利标题（中）： 类视黄醇X受体的细胞质活性及其通过配体和二聚化的调节
-
申请号： US10918116申请日： 2004-08-13
-
公开(公告)号： US08105798B2公开(公告)日： 2012-01-31
- 发明人: Xiao-kun Zhang , Xihua Cao , Wen Liu
- 申请人： Xiao-kun Zhang , Xihua Cao , Wen Liu
- 申请人地址： US CA La Jolla
- 专利权人： The Burnham Institute
- 当前专利权人： The Burnham Institute
- 当前专利权人地址： US CA La Jolla
- 代理机构： Knobbe Martens Olson & Bear LLP
- 主分类号： G01N33/53
- IPC分类号： G01N33/53
摘要：
This invention relates to methods for identifying agents useful for treatment of diseases and pathological conditions affected by Retinoid X Receptor apoptosis. The invention also relates to methods for treating diseases and pathological conditions affected by RXR apoptosis. The invention includes compositions that are useful in the study and treatment of diseases and pathological conditions affected by RXR apoptosis.
公开/授权文献
信息查询
IPC分类:
